AstraZeneca is a U.K.-based global biopharmaceutical company that develops and markets prescription medicines in oncology, cardiovascular, respiratory, and other therapy areas.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Bridgewater | 55 | New buy | 8,188 | $1,322,116 | 0.0% |
| Steve Cohen / Point72 | 75 | Added +133% | 1,733,118 | $279,846,565 | 0.3% |
| Ancora | 42 | Added +44% | 1,150 | $185,690 | 0.0% |
| Larry Robbins / Glenview | 61 | Trimmed -32% | 125,678 | $20,293,227 | 0.3% |
| Paul Tudor Jones / Tudor | 61 | Trimmed -62% | 19,300 | $3,116,371 | 0.0% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-03-31 | Alan Armstrong senate | BUY | $1,001 - $15,000 | PTR |
| 2026-03-30 | Alan Armstrong senate | BUY | $15,001 - $50,000 | PTR |
| 2025-12-18 | Gilbert Cisneros CA31 | BUY | $1,001 - $15,000 | PTR |
| 2025-12-08 | Julia Letlow LA05 | BUY | $1,001 - $15,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.